The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: A retrospective pooled analysis of data from randomized, placebo-controlled clinical trials

Current Medical Research and Opinion

Volumn 21, Issue 11, 2005, Pages 1701-1709

  Rosen, Raymond C ^a   Shabsigh, Ridwan ^b   Kuritzky, Louis ^c   Wang, Wei Christine ^d   Sides, Gregory D ^d  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

Erectile dysfunction; Satisfaction; Sexual behavior; Tadalafil

Indexed keywords

PLACEBO; TADALAFIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERECTILE DYSFUNCTION; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE;

ADULT; AGED; CARBOLINES; COITUS; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PENILE ERECTION; PERSONAL SATISFACTION; PHOSPHODIESTERASE INHIBITORS; PLACEBOS; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES;

EID: 27944465593     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X65538     Document Type: Article

References (40)

1. National Institutes of Health. NIH consensus conference. Impotence. [NIH Consensus Development Panel on Impotence]. J Am Med Assoc 1993;270:83-90
2. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30
3. Aytaç IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. Br J Urol Int 1999;84:50-6
4. Rosen RC, Fisher WA, Eardley I, et al. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 2004;20:607-17
5. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. J Am Med Assoc 1999;281:537-44
6. Strand J, Wise TN, Fagan PJ, et al. Erectile dysfunction and depression: category or dimension? J Sex Marital Ther 2002;28:175-81
7. Araujo AB, Durante R, Feldman HA, et al. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998;60:458-65
8. Shabsigh R, Klein LT, Seidman S, et al. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998;52:848-52
9. Smith AD. Psychologic factors in the multidisciplinary evaluation and treatment of erectile dysfunction. Urol Clin North Am 1988;15:41-51
10. Sanchez-Cruz JJ, Cabrera-Leon A, Martin-Morales A, et al. Male erectile dysfunction and health-related quality of life. Eur Urol 2003;44:245-53
11. Fugl-Meyer K, Fugl-Meyer AR. Sexual disabilities are not singularities. Int J Impot Res 2002;14:487-93
12. Jannini EA, Lenzi A. Introduction to the integrated model: medical, surgical and psychological therapies for the couple. J Endocrinol Invest 2003;26:128-31
13. Paige NM, Hays RD, Litwin MS, et al. Improvement in emotional well-being and relationships of users of sildenafil. J Urol 2001;166:1774-8
14. Muller MJ, Benkert O. Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil. J Affect Disord 2001;66:255-61
15. Fugl-Meyer AR, Lodnert G, Branholm IB, et al. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997;9:141-8
16. Muller MJ, Ruof J, Graf-Morgenstern M, et al. Quality of partnership in patients with erectile dysfunction after sildenafil treatment. Pharmacopsychiatry 2001;34:91-5
17. Sáenz de Tejada I, Anglin G, Knight JR, et al. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 2002;25:2159-64
18. Montorsi F, Nathan HP, McCullough A, et al. Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial. J Urol 2004;172:1036-41
19. Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002;168:1332-6
20. Porst H, Padma-Nathan H, Giuliano F, et al. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology 2003;62:121-5
21. Carson CC, Rajfer J, Eardley I, et al. The efficacy and safety of tadalafil: an update. Br J Urol Int 2004;93:1276-81
22. Carson C, Shabsigh R, Segal S, et al. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers. Urology 2005;65:353-9
23. Skoumal R, Chen J, Kula K, Breza J, et al. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction. Eur Urol 2004;46:362-9
24. Carson C, Giuliano F, Goldstein I, et al. The 'effectiveness' scale - therapeutic outcome of pharmacologic therapies for ED: an international consensus panel report. Int J Impot Res 2004;16:207-13
25. Althof SE, Corty EW, Levine SB, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999;53:793-9
26. Lewis R, Bennett CJ, Borkon WD, et al. Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire. Urology 2001;57:960-5
27. van Lankveld JJ, van Koeveringe GA. Predictive validity of the Golombok Rust Inventory of Sexual Satisfaction (GRISS) for the presence of sexual dysfunctions within a Dutch urological population. Int J Impot Res 2003;15:110-6
28. Swindle RW, Cameron AE, Lockhart DC, et al. The psychological and interpersonal relationship scales: assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav 2004;33:19-30
29. Latini DM, Penson DF, Colwell HH, et al. Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J Urol 2002;168:2086-91
30. Latini DM, Penson DF, Lubeck DP, et al. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. J Urol 2003;169:1437-42
31. MacDonagh R, Ewings P, Porter T. The effect of erectile dysfunction on quality of life: psychometric testing of a new quality of life measure for patients with erectile dysfunction. J Urol 2002;167:212-7
32. Wagner TH, Patrick DL, McKenna SP, et al. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996;5:443-9
33. Woodward JM, Hass SL, Woodward PJ. Reliability and validity of the sexual life quality questionnaire (SLQQ). Qual Life Res 2002;11:365-77
34. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction [Sildenafil Study Group]. New Engl J Med 1998;338:1397-404
35. Montorsi F, McDermott TE, Morgan R, et al. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 1999;53:1011-8
36. Meuleman E, Cuzin B, Opsomer RJ, et al. A dose-escalation study to assess the efficacy and safety of sildenafil citrate in men with erectile dysfunction. Br J Urol Int 2001;87:75-81
37. Donatucci C, Taylor T, Thibonnier M, et al., for the Vardenafil Study Group. Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction. J Sex Med 2004;1:185-92
38. Hatzichristou D, Cuzin B, Martin-Morales A, et al., for the Vardenafil Study Group. Vardenafil improves satisfaction rates, depressive symptomatology, and self-confidence in a broad population of men with erectile dysfunction. J Sex Med 2005;2:109-16
39. Klotz T, Mathers M, Klotz R, et al. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra®)? Int J Impot Res 2004;16:1-3
40. Ichikawa T, Takao A, Manabe D, et al. The female partner's satisfaction with sildenafil citrate treatment of erectile dysfunction. Int J Urol 2004;11:755-62